Doximity

Natera

Insulet

Jazz Pharmaceuticals

Premier

Roivant Sciences Ltd

United Therapeutics

Exelixis

ResMed

DaVita

First Trust Health Care AlphaDEX Fund

FXH tracks a tiered, equal-weighted index of large- and mid-cap US health care companies. Holdings are selected and weighted based on various growth and value criteria.

Making its debut on 05/08/2007, smart beta exchange traded fund First Trust Health Care AlphaDEX ETF (FXH) provides investors broad exposure to the Health Care ETFs category of the market.

Is First Trust Health Care AlphaDEX ETF (FXH) a Strong ETF Right Now?

The First Trust Health Care AlphaDEX ETF (FXH) was launched on 05/08/2007, and is a passively managed exchange traded fund designed to offer broad exposure to the Healthcare - Broad segment of the equity market.

Should You Invest in the First Trust Health Care AlphaDEX ETF (FXH)?

ARK Genomic Revolution Multi-Sector ETF

iShares Global Healthcare ETF

Vanguard Health Care ETF

SPDR S&P Biotech ETF

Health Care Select Sector SPDR Fund

The best healthcare ETFs patch investors into an area of the market that offers both defensive properties and long-term growth.

Best Healthcare ETFs To Buy Now

FXH launched in May 2007 and has amassed $1.26 billion in assets under management. Its 0.62% expense ratio is significant, but its long-term returns are pretty solid. FXH trades at a 30% discount on forward earnings compared to VHT, making it an exciting short-term tactical play. Importantly, the fund is also strong on growth, quality, and diversification. Health Care stocks are poised to outperform, with large-caps delivering earnings surprises that were second-best last quarter. FXH's selections also did well, especially in sales.

FXH: A Short-Term Tactical Health Care Play Worth Considering

Principal Healthcare Innovators Index ETF

Fidelity MSCI Health Care ETF

Amplify Treatments Testing & Advancements ETF

Global X Health Care Covered Call & Growth ETF

SPDR S&P Insurance ETF

Direxion Daily Pharmaceutical & Medical Bull 3X Shares

Invesco DWA Healthcare Momentum ETF

Invesco S&P 500 Equal Weight Health Care ETF

SPDR Portfolio S&P 500 Growth ETF

SPDR Portfolio S&P 500 Value ETF

Amplify Weight Loss Drug & Treatment ETF

SPDR S&P Health Care Equipment ETF

SPDR S&P Health Care Services ETF

SPDR S&P Pharmaceuticals ETF

Sometimes it feels like it's Nvidia's world and we all just live in it. Why bother with anything else?

Finding Opportunity in Unloved Healthcare ETFs

Best Healthcare ETFs to Buy Now

Global X Longevity Thematic ETF 

Virtus LifeSci Biotech Clinical Trials ETF

VanEck Vectors Biotech ETF

Virtus LifeSci Biotech Products ETF

BlackRock Future Health ETF

Loncar Cancer Immunotherapy ETF

Global X Telemedicine & Digital Health ETF

First Trust NYSE Arca Biotechnology Index Fund

First Trust Nasdaq Pharmaceuticals ETF 

Global X Genomics & Biotechnology ETF

 Franklin Genomic Advancements ETF

ROBO Global Healthcare Technology and Innovation ETF

iShares Nasdaq Biotechnology ETF

Invesco Nasdaq Biotechnology ETF

iShares Genomics Immunology and Healthcare ETF

iShares U.S. Pharmaceuticals ETF

iShares U.S. Healthcare Providers ETF

iShares U.S. Medical Devices ETF

iShares U.S. Healthcare ETF

Eli Lilly

Global X Longevity Thematic ETF

First Trust Indxx Medical Devices ETF

Merck

Novo Nordisk

Invesco Dynamic Biotechnology & Genome ETF

Simplify Health Care ETF

Invesco Dynamic Pharmaceuticals ETF

VanEck Vectors Pharmaceutical ETF

Invesco S&P SmallCap Health Care ETF

ALPS Medical Breakthroughs ETF

Wisdomtree BioRevolution Fund

How a recession could impact health care stocks in 2023. As Covid continues, what it could mean for the health care sector.

Can Health Care Stocks Outperform Again In 2023?

Broadly speaking, the healthcare sector isn't on fire this year, but analysts are increasingly bullish on the group, citing attractive quality and valuation traits, among other factors. While the sector isn't yet ablaze in 2022, some big names in the group are delivering for investors, underscoring the point that quality is a virtue.

This Healthcare ETF Has Compelling Prognosis

iShares U.S. Home Construction ETF

Global X U.S. Infrastructure Development ETF

Invesco Dynamic Food & Beverage ETF

Invesco PureBeta MSCI USA Small Cap ETF

Vanguard Financials ETF

Wall Street has rallied hard lately on vaccine distribution, decent corporate earnings and strong cash pile-up at the household and corporate levels.

Stocks Near Record Highs: Buy 6 Top-Ranked ETFs at Cheap Valuation

iShares Evolved U.S. Innovative Healthcare ETF

Upbeat earnings, COVID-19-related sales, compelling valuation and lucrative dividend prospects are boosting pharma and healthcare ETFs.

Pharma & Healthcare ETFs at a One-Year High: Here's Why

The broader medical sector should gain on decent earnings expectations and higher COVID-19-related sales

Time for Pharma and Healthcare ETFs?

NETLease Corporate Real Estate ETF

Nuveen Short-Term REIT ETF

iShares Residential Real Estate ETF

SPDR Dow Jones REIT ETF

The U.S. economic backdrop and investors' sentiments have remained mixed in recent weeks.

2 Sector ETFs Hovering Around All-Time Highs

Global X China Biotech Innovation ETF

iShares Evolved U.S. Healthcare Staples ETF

SPDR S&P 500 ETF Trust

UnitedHealth Group

Decent earnings growth picture and valuation as well as solid deals activities have been favoring healthcare sector at the current level.

Are Healthcare ETFs Poised for a Comeback?

Direxion Daily Healthcare Bull 3x Shares

abrdn Healthcare Investors 

abrdn Life Sciences Investors 

Defiance Nasdaq Junior Biotechnology ETF

John Hancock Multifactor Healthcare ETF

Direxion Daily S&P Biotech Bear 3X Shares

Direxion Daily S&P Biotech Bull 3X Shares

ProShares UltraShort Health Care

ProShares Ultra Health Care

Pacer BioThreat ETF

The first quarter of 2021 was challenging for the biotechnology industry, as the selloff in March represented a sharp reversal from record highs in February. While the sector has remained relatively resilient throughout the pandemic, we expect a full recovery in the latter half of this year, as operations that were disrupted return to normal.

Biotech Innovations Remain At Forefront

AbbVie

LeMaitre Vascular

The advantage for dividend investors in this sector is the wide choice of large and well-established companies. AbbVie is a drug company with strong exposure to the immunology and the oncology markets.

Healthcare: A Wide Choice Of Large And Well-Established Companies

The fund FXH has hit a 52-week high on May 28. Can it rally further?

Healthcare ETF (FXH) Hits New 52-Week High

First Trust Dow Jones Internet Index Fund

First Trust NASDAQ-100 Technology Sector Index Fund

Vanguard Consumer Discretionary ETF

Consumer Discretionary Select Sector SPDR Fund

These sector ETFs emerged winners in the 11-year old bull market and may survive despite the coronavirus scare.

4 Sector ETF Winners of Bull Market Look Resilient to Virus

Invesco Dynamic Building & Construction ETF

Vanguard Real Estate ETF

The U.S. labor market has been in great shape defying slowdown worries. Unemployment rate fell to a fresh 49-year low in April.

Solid US Labor Market Puts Focus on 3 Sector ETFs & Stocks

For the First Trust Health Care AlphaDEX Fund ETF, we found that the implied analyst target price for the ETF based upon its underlying holdings is $85.29 per unit.

Add Up The Pieces: The First Trust Health Care AlphaDEX Fund ETF Could Be Worth $85

For the First Trust Health Care AlphaDEX Fund ETF, we found that the implied analyst target price for the ETF based upon its underlying holdings is $85.17 per unit.

Implied First Trust Health Care AlphaDEX Fund ETF Analyst Target Price: $85

News for First Trust Health Care AlphaDEX Fund ETF (FXH)